When analysing all patients receiving tamoxifen, high tumour expression of 17βHSD14 significantly lowered local recurrence rates, and the current study thus supports findings from our previous study in which HSD17B14 transcripts were analysed in a different patient group, all receiving tamoxifen [8]. This evidence concerns the gene HSD17B14 and neoplasm.